InsiderTrades

Form 4 for NKE Nike, Inc.

Accepted 2021-11-16 00:00:00 ET · period of report 2021-11-15 · accession 0001127602-21-029370 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-11-16 2021-11-15 NKE Krane Hilary K EVP, CAO, GC S - Sale+OE $169.70 -10.8K 151.3K -7% -$1.82M
DM 2021-11-16 2021-11-15 NKE Krane Hilary K EVP, CAO, GC M - OptEx $55.17 +10.8K 161.3K +7% +$593.1K
DM 2021-11-16 2021-11-15 NKE Krane Hilary K EVP, CAO, GC M - OptEx $0.00 -10.8K 107.5K -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class B Common Stock 2021-11-15 S D 10,000 $169.70 151,335.79 D — — (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market sales of Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
2 Common Class B Common Stock 2021-11-15 S D 750 $169.70 151,335.79 D — — (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market sales of Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
3 Common Class B Common Stock 2021-11-15 M A 750 $38.76 152,085.79 D — — (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market sales of Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans. (F2) Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.
4 Common Class B Common Stock 2021-11-15 M A 10,000 $56.40 161,335.79 D — — (F1) Exercise and sale were pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market sales of Company stock by officers and directors are permitted only after the first full trading day after the public release of quarterly earnings and ending on the fourteenth day of the third month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
5 Derivative Non-Qualified Stock Option (Right to Buy) 2021-11-15 M D 750 $0.00 0 D $38.76 · — to 2024-07-18 750 Class B Common Stock (F4) Stock Option granted on 07/18/2014 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.
6 Derivative Non-Qualified Stock Option (Right to Buy) 2021-11-15 M D 10,000 $0.00 107,500 D $56.40 · — to 2025-07-17 10,000 Class B Common Stock (F5) Stock Option granted on 07/17/2015 and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.